← The Wire
VCELNasdaq
Vericel Corp
Biological Products, (No Diagnostic Substances) · MI · CIK 887359
Vericel provides advanced cell therapies and specialty biologics for sports medicine and severe burn care
$1.91B
Market cap
$45.07
Last close
-2.5%
1D
+11.4%
5D
772K
Volume
Price · last 39 sessions+23.5%
May 4L $32.82 · H $46.23Jun 29
308
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end
8-KBylaw AmendmentMay 18, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 20268-KShareholder VoteMay 1, 2026DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 19, 2026DEF 14ADEFINITIVE PROXY STATEMENTMar 19, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KResults of Operations · Reg FD DisclosureJan 13, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QJul 31, 20258-KResults of OperationsJul 31, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KExecutive Change · Shareholder VoteMay 2, 20258-KReg FD DisclosureApr 14, 2025DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 20, 2025DEF 14ADEFINITIVE PROXY STATEMENTMar 20, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KResults of Operations · Reg FD DisclosureJan 14, 202510-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KCompany UpdateAug 26, 20248-KCompany UpdateAug 15, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 20248-KShareholder VoteMay 3, 2024DEFA14AVERICEL CORP - DEFA14AMar 21, 2024DEF 14AVERICEL CORP - DEF 14AMar 21, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 29, 20248-KResults of Operations · Reg FD DisclosureJan 9, 202410-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KCompany UpdateSep 20, 202310-Q10-QAug 2, 20238-KResults of OperationsAug 2, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 20238-KExecutive Change · Shareholder VoteMay 5, 2023DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 23, 2023DEF 14ADEFINITIVE PROXY STATEMENTMar 23, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 2023SC 13GCONESTOGA CAPITAL ADVISORSJan 19, 20238-KResults of Operations · Reg FD DisclosureJan 10, 20238-KCompany UpdateDec 29, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KMaterial Agreement · New Debt / ObligationAug 2, 202210-Q10-QMay 4, 20228-KResults of OperationsMay 4, 20228-KExecutive Change · Shareholder VoteApr 29, 2022DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 17, 2022DEF 14ADEFINITIVE PROXY STATEMENTMar 17, 20228-KExecutive ChangeFeb 24, 202210-K10-KFeb 24, 20228-KResults of OperationsFeb 24, 2022SC 13GVERICEL CORPORATIONFeb 14, 2022SC 13GSC 13GFeb 10, 20228-KMaterial Agreement · New Debt / ObligationFeb 2, 20228-KResults of Operations · Reg FD DisclosureJan 12, 202210-Q10-QNov 9, 20218-KResults of OperationsNov 9, 20218-KMaterial AgreementAug 27, 202110-Q10-QAug 4, 20218-KResults of OperationsAug 4, 20218-KCompany UpdateJun 29, 20218-KExecutive ChangeJun 21, 20218-KExecutive ChangeJun 2, 202110-Q10-Q 3.31.2021May 5, 20218-KResults of OperationsMay 5, 20218-KShareholder VoteApr 29, 2021DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 19, 2021
Insider Activity
In the 90 days to Mar 23, 2026: 4 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Hagen HeidiDirector | Sell | 15,000 | $32.41 | $486K |
| Mar 2, 2026 | Flynn Sean C.Chief Legal Officer | Sell | 15,000 | $35.36 | $530K |
| Mar 2, 2026 | Halpin MichaelChief Operating Officer | Sell | 10,305 | $35.30 | $364K |
| Mar 2, 2026 | Flynn Sean C.Chief Legal Officer | Sell | 6,421 | $34.75 | $223K |
| Feb 11, 2026 | Mclaughlin Kevin FDirector | Sell | 7,000 | $34.66 | $243K |
| Jan 7, 2026 | Halpin MichaelChief Operating Officer | Sell | 10,000 | $40.48 | $405K |
| Dec 3, 2025 | Wotton Paul KDirector | Sell | 2,500 | $37.83 | $95K |
| Dec 2, 2025 | Wotton Paul KDirector | Sell | 2,500 | $37.97 | $95K |
| Dec 2, 2025 | Hopper Jonathan MarkChief Medical Officer | Sell | 1,652 | $39.14 | $65K |
| Nov 11, 2025 | Halpin MichaelChief Operating Officer | Sell | 2,642 | $40.41 | $107K |
| Nov 10, 2025 | Mclaughlin Kevin FDirector | Sell | 7,000 | $38.59 | $270K |
| Nov 6, 2025 | Halpin MichaelChief Operating Officer | Sell | 7,358 | $40.47 | $298K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance